Zobrazeno 1 - 9
of 9
pro vyhledávání: '"KO-YUN CHANG"'
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundThe disproportionate burden of COVID-19 pandemic has become a major concern in the United States (US), but the association between COVID-19 case-fatality rate (CFR) and factors influencing health outcomes at a state level has not been evalu
Externí odkaz:
https://doaj.org/article/84713376680d42978ff060096ba88a54
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 11, p 2366 (2021)
Background: Sarcoidosis is associated with significant morbidity and rising health care utilization, which contribute to the health care burden and disease outcome. In the United States (US), evaluation of sarcoidosis mortality by individual states h
Externí odkaz:
https://doaj.org/article/d17ea5772f2b44bf8bd539d41d76f92e
Publikováno v:
Sleep Medicine. 90:204-213
Sleep apnea is one of the most common sleep disorders in the United States (US). Although the prevalence, risk factors, and clinical presentations of sleep apnea vary by racial groups, the racial disparity in sleep apnea-related mortality remains unc
Publikováno v:
Annals of the American Thoracic Society. 20(1)
Publikováno v:
Annals of the American Thoracic Society; Jan2023, Vol. 20 Issue 1, p47-57, 32p
Publikováno v:
Chest. 162:A301
Publikováno v:
JAMA Network Open
Key Points Question Are county-level health disparities associated with chronic lower respiratory disease (CLRD) outcomes in New York state? Findings In this cross-sectional study including 60 335 CLRD hospitalizations and 20 612 CLRD deaths in 62 co
Publikováno v:
Blood. 138:3066-3066
INTRODUCTION : Leukemia is the seventh leading cause of cancer death in the United States (US) in 2021. The Mortality Incidence Rate Ratio, also known as Mortality-to-Incidence Ratio (MIR), is calculated by dividing the mortality rate by the incidenc
Publikováno v:
Journal of Clinical Oncology. 37:1548-1548
1548 Background: Breast cancer is the most commonly diagnosed cancer and second leading cause of cancer deaths among women in the United States. The cancer mortality-to-incidence ratio (MIR) provides a population-based indicator of cancer survival an